Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Net Margin % : -31,240.91% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Great Novel Therapeutics Biotech & Medicals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Great Novel Therapeutics Biotech & Medicals's Net Income for the six months ended in Dec. 2023 was NT$-27.49 Mil. Great Novel Therapeutics Biotech & Medicals's Revenue for the six months ended in Dec. 2023 was NT$0.09 Mil. Therefore, Great Novel Therapeutics Biotech & Medicals's net margin for the quarter that ended in Dec. 2023 was -31,240.91%.

The historical rank and industry rank for Great Novel Therapeutics Biotech & Medicals's Net Margin % or its related term are showing as below:

ROCO:7427' s Net Margin % Range Over the Past 10 Years
Min: -33948.86 Med: -5691.59 Max: -1252.36
Current: -1268.87

ROCO:7427's Net Margin % is ranked worse than
76.62% of 1018 companies
in the Biotechnology industry
Industry Median: -150.095 vs ROCO:7427: -1268.87

Great Novel Therapeutics Biotech & Medicals Net Margin % Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Novel Therapeutics Biotech & Medicals Net Margin % Chart

Great Novel Therapeutics Biotech & Medicals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-33,948.86

-5,691.59

-10,329.44

-1,268.87

Great Novel Therapeutics Biotech & Medicals Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial					-5,586.36	-5,304.63	-	-714.99	-31,240.91

Competitive Comparison of Great Novel Therapeutics Biotech & Medicals's Net Margin %

For the Biotechnology subindustry, Great Novel Therapeutics Biotech & Medicals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Great Novel Therapeutics Biotech & Medicals's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Great Novel Therapeutics Biotech & Medicals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Great Novel Therapeutics Biotech & Medicals's Net Margin % falls into.

Great Novel Therapeutics Biotech & Medicals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Great Novel Therapeutics Biotech & Medicals's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-61.54	/	4.85
	=	-1,268.87 %

Great Novel Therapeutics Biotech & Medicals's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-27.492	/	0.088
	=	-31,240.91 %

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Great Novel Therapeutics Biotech & Medicals Net Margin % Related Terms

Thank you for viewing the detailed overview of Great Novel Therapeutics Biotech & Medicals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Great Novel Therapeutics Biotech & Medicals (ROCO:7427) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503

Website

http://www.gntbm.com.tw

Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Headlines

No Headlines